My research activity is aimed at the design of new compounds that are able to activate or modulate some apoptotic and autophagic processes in the treatment of chronic myeloid leukemia in patients, infact this design is done in in vitro experimentation on peripheral blood and bone marrow withdrawals,after written consent of the patient.